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ASTRACT  
 
Potassium ferrate(VI) (K2FeO4) has advantageous properties such as a dual function as an 
oxidant and disinfectant with a non-toxic byproduct, iron(III), which makes it an environmentally 
friendly chemical for water treatment.  This paper presents an assessment of the potential of 
ferrate(VI) to oxidize representative endocrine disruptors (EDs) and antimicrobials during water 
treatment using information about reaction kinetics and products.  Selected EDs were bisphenol A 
(BPA) and 17α-ethynylestradiol (EE2), estrone (E1), 17β-estradiol (E2), and estriol (E3), and 
sulfonamides and tetracycline were representative pharamaceuticals.  The second-order rate 
constants, k, of the oxidation reactions at neutral pH were in the range from 6.50 –11.8 x 102 M-
1s-1 and 0.79 – 15.0x102 M-1s-1 for EDs and sulfonamides, respectively.  At a 10 mg/L K2FeO4 
dose, half-lives of the oxidation reaction would be in seconds at a neutral pH.  The values of k, 
and the reaction half-lives, varied with pH.  Oxidation products from the reaction with BPA and 
sulamethoxazole (SMX) at molar ratios of  5:1 were found to be relatively less toxic.  Overall, 
ferrate(VI) oxidation could be an effective treatment method for the purification of waters 
containing these particular EDs and antimicrobials.     
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INTRODUCTION  
 
Endocrine disruptors (EDs) are compounds that mimic natural hormones in the endocrine 
system thus cause adverse effects on human and wildlife (Lutz & Kloas 1999).  Examples of 
EDs include natural steroids hormones, synthetic hormones, alkylephenols, bisphenol-A, and 
phthalate plasticizers.  In recent years, several studies have found a variety of EDs in surface 
waters (Snyder et al. 2003; Westerhoff et al. 2006). In addition to EDs, pharmaceuticals and 
personal care products (PPCPs) have also been found in the aquatic environment (Ternes et al. 
2004; Khetan & Collins 2007).  Although levels of pharmaceuticals have been determined in the 
concentration range of ng/L to- µg/L, mixtures of pharmaceuticals even at ng/L can inhibit cell 
proliferation (Gibson et al. 2005; Pomati et al. 2006).  EDs and PPCPs may thus affect the 
ecology of the environment (Jobling et al. 1998; Mills & Chichester 2005).  For example, some 
EDs have demonstrated mutagenic and carcinogenic effects (Khetan & Collins 2007).  Of the 
several compounds of PPCPs, detection of antibiotics is of concern due to the possibility of 
increased bacterial resistance (Gould 1999).   
In general, drinking water utilities abstract water from various sources such as, ground 
water, rivers, streams, springs, or lakes in a watershed; small communities generally receive 
water from aquifers, while large metropolitan areas receive water from surface sources.  In most 
cases source waters require treatment before use in order to meet national quality standards.  
Human populations may possibly be exposed to EDs and antibiotics through drinking water 
produced from surface and ground waters contaminated with such compounds in wastewater 
discharges and urban runoff (Weyer & Riley 2001; Snyder et al. 2003; Ongerth & Khan 2003).  
Importantly, the existence of such compounds in treated water indicates that plant treatment 
processes do not adequately remove these compounds (Ternes et al. 2002; Carbala et al. 2004; 
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Miao et al. 2004).  Among the oxidation processes applied in water treatment, chlorine is 
commonly used as a pre-oxidant and disinfectant.  Although chlorine is effective in oxidizing 
EDs and antibiotics (Deborde et al. 2004; Dodd et al. 2004; Lee et al. 2004; Pinkson et al. 2004; 
Dodd & Hunag 2007), oxidation reactions produce biologically active by-products (Hu et al. 
2002, 2003).  Those who favour the use of chlorine usually cite its ability to react with ammonia 
and organic nitrogen to produce chloroamines (Pinkson et al. 2004), which help to reduce 
trihalomethanes.  However, the reactivity of chloroamines with compounds is much slower than 
that of free chlorine (HOCl/OCl-), and there are growing concerns about the formation of 
nitrosomines and other nitrogen-containing byproducts in chloraminated waters.   
Alternatively, ozone can be applied, which can effectively oxidize EDs and antibiotics 
(Huber et al. 2003, 2005; Ning et al. 2007), however, due to the potential formation of the 
bromate ion and other organic by-products, ozonation is not always suitable.  Chlorine dioxide 
(ClO2) is another oxidant used for disinfection, but its use is restricted to high quality water such 
as treated surface water (Gates 1998).  Dosing of ClO2 must be kept low, for example, in the 
United States, dosages ranging from 1.0 to 1.4 mgL-1 are used mainly for the preoxidation of 
surface water (Gates 1998).  Reduction of ClO2 produces chlorite ion, which is considered a 
blood poison (Condies 1986) and higher dosages of ClO2 (>1.4 mgL-1) are likely to produce 
chlorite levels that exceed the USEPA standard of 1 mgL-1.   
Ferrate(VI) (FeVIO42-) is an emerging water-treatment chemical, which can address the 
concerns raised by the currently used oxidants (Sharma 2007a).  Interestingly, ferrate(VI) does 
not react with bromide ion; carcinogenic bromate ion would thus not be produced in the 
treatment of bromide-containing water (Sharma 2006b).  Additionally, ferrate(VI) exhibits many 
advantageous properties, including a higher reactivity and selectivity than traditional oxidant 
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alternatives, and a significant capability as a disinfectant, antifoulant, and coagulant (Jiang & 
Lloyd 2002; Sharma 2002; Sharma et al. 2005a).  The spontaneous decomposition of ferrate(VI) 
in water forms molecular oxygen (eq 1). 
2 FeO42- + 5 H2O  2 Fe3+ + 3/2 O2 + 10 OH-     (1) 
Moreover, the by-product of ferrate(VI) is a non-toxic ferric ion, Fe(III).  This fact makes 
ferrate(VI) an “environmentally friendly” oxidant. Additionally, the ferric oxide produced from 
ferrate(VI) acts as an effective coagulant that is suitable for the removal of metals, non-metals, 
radionuclides, and humic acids (Sharma 2002, Sharma et al. 2005b).   
This paper describes the potential of ferrate(VI) to oxidize representative EDs and 
antibiotics during water and wastewater treatment.  Reaction kinetics information for the 
oxidation of bisphenol (BPA), steroid estrogens, and antibiotics by ferrate(VI) is provided to 
determine nominal half-lives of the oxidation processes.  The current knowledge of the nature of 
products from the oxidation is summarized. 
 
ENDOCRINE DISRUPTORS   
BPA  and Estrogens 
Among the prominent EDs of environmental significance, two synthetic endocrine disrupting 
chemicals, bisphenol A (BPA) and 17α-ethynylestradiol (EE2), and three natural EDCs, estrone 
(E1), 17β-estradiol (E2), and estriol (E3) were chosen to investigate and quantify their reaction 
kinetics with ferrate(VI) (Li et al. 2005, 2007); all five have a common character in that they are 
phenolic-type compounds. Details of the experiments have been reported elsewhere (Li et al. 
2005, 2007) and which involved the use of high purity potassium ferrate prepared by a method 
based on the oxidation of ferric nitrate with hypochlorite (Li et al. 2005). The reactions were 
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shown to follow an overall second-order kinetic model and the rate constants at pH 7.0 and 8.0 at 
25 oC are given in Table 1.  The rates at the two pH values were calculated from the individual 
rates for the reactions of ferrate(VI) species (monoprotonated, HFeO4- and un-protonated, FeO42-
) with un-dissociated (ED) and dissociated (ED-) endocrine disruptor species.  The rate constants 
for the oxidation of BPA and EE2 by ferrate(VI) at pH 8.0 were found to be lower than that at 
pH 7.0 (Table 1); this was also observed by Lee et al (2005).  Interestingly, no significant 
differences in rate constants for the oxidation of the estrogens E1, E2, and E3 were observed 
(Table 1) and therefore removal of these estrogens by ferrate(VI) can be carried out at either pH 
8.0 or 7.0 without any difference in  the effectiveness of the process.  The greater degradation 
performance  of BPA and EE2 by ferrate(VI)  at the lower pH may be related to the higher 
oxidizing power of HFeO4- than that of FeO42- and that the fraction of HFeO4- increases with 
decreasing pH.  Overall, the extent of the ferrate(VI) oxidation will vary with the aqueous 
conditions since pH, in particular, affects the nature of the ferrate(VI) ion (degree of protonation) 
and the extent of dissociation of the EDs.   
Generally, the application of potassium ferrate(VI) can achieve a major removal of selected 
EDs within seconds (Table 1). The reaction of BPA with ferrate(VI) was studied in detail in 
order to identify the formation of intermediate reaction products and the BPA degradation 
pathways.  From the analyses carried out by LC/MS-MS and GC/MS-MS, nine specific 
compounds were identified, including p-isopropylphenol, p-isopropenylphenol, 4-
isopropanolphenol, and dicarboxylic acids (eg. oxalic acid). Whilst under some conditions (e.g. 
ferrate:BPA molar ratio ~ 5:1) BPA can be completely degraded in less than 5 minutes, the 
degree of organic mineralization was significantly less than 100%, indicating the presence of 
reaction products which persist well beyond the disappearance of the BPA (Li et al. 2007).  A 
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pathway of BPA degradation with ferrate(VI) has been proposed as described by Scheme I. 
 
ANTIMICROBIALS  
Sulfonamides  
The rate-law for the oxidation of sulfonamide (S) by ferrate(VI) were found to be first-order for 
each reactant and can be written as: 
-d[Fe(VI)]/dt = k[Fe(VI)]tot[S]tot       (2) 
where k represents the second-order rate constant for the reaction of ferrate(VI) with 
sulfonamide, [Fe(VI)]tot represents the total concentration of Fe(VI) species, and [S]tot represents 
the total concentration of each sulfonamide species. The observed second-order rate constants 
decreased non-linearly with increasing pH (Sharma et al. 2006).  The values of k at pH 7.0 and 
8.0 at 25 oC are reported in Table 1.  If there is excess Fe(VI) concentration (10 mgL-1 K2FeO4) 
relative to the sulfonamides in water, as might be expected in practice, the half-lives of the 
reactions would be short and in the range from 39.3 to 365 s at pH 8.0 (Table 1).  The reaction 
rates are pH dependent, thus, so are the half-lives of the reactions (Table 1).  At pH 7.0 under the 
same conditions, the half-lives would be very short from 9.2 – 33.9 s (Table 1).  It should also be 
pointed out that reaction rates are also temperature dependent, gaving rise to different activation 
energies of the reaction (Sharma et al. 2006).  Therefore, the reaction half-lives will vary 
significantly with the aqeous environmental conditions.  
The oxidation of sulfamethoxazole (SMX) by ferrate(VI) has been found to follow a 
molar stoichiometry of 4:1 ([Fe(VI):[SMX]).  An evolution of one mole of oxygen per mole of 
SMX was determined (eq 3).  
4 HFeO4-   +    SMX   →     4 Fe(III) + O2 + Product(s)             (3) 
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For product analysis of the reaction, 0.750 L of 2.0x 10-4 M SMX was oxidized with 0.750 L of 
0.001 M Fe(VI) at a pH of 9.0 for 3 hours.  The reaction mixture was frozen and lyophilized 
using a Freeze Dry System/Freezone 4.5 (Labconco); followed by extraction procedures (Sharma 
et al. 2006).  Products of the reaction were determined using thin-layer chromatography (TLC), 
column chromatography, infrared (IR) spectroscopy, 1H nuclear magnetic resonance (NMR) 
spectroscopy, and mass spectrometry (ESI MS) techniques.   Three products A, B, and C  were 
determined as given in Scheme II.   
Interestingly, the reaction resulted in the oxidation of either the isoxazole moiety or the 
aniline unit of SMX by ferrate(VI).  Thus, product A indicates opening of the isoxazole moiety 
while the presence of predominantly a nitroso and a nitro group in product C and B, respectively, 
indicates ferrate(VI) attack at the aniline unit. It is possible that at higher molar ratios of 
ferrate(VI) to SMX, simultaneous oxidation of both the isoxazole and the aniline units might 
occur.  It is possible that such products carry increased polarity and might have been retained on 
the column during chromatography.  Therefore the three products described in Scheme 1 may 
not necessarily represent all the products of ferrate(VI) oxidation, but rather the ones that were 
isolated and characterized.  Importantly, the oxidation of the compound by ferrate(VI), whether 
by the attack on the aromatic or isoxazole rings, will undoubtedly cause the oxidized product to 
have a differing biological binding property.  It is expected that an oxidation of the amino group 
and/or an oxidation of the isoxazole ring (which leads to its potential opening/destruction) will 
change its binding properties sufficiently rendering it less of a mimic for the important p-
aminobenzoic acid.  The latter is necessary in the synthesis of the essential vitamin: folic acid.  
Thus ferrate(VI) not only removes SMX in water, but also produces by-products that are 
expected to be less toxic.   
 9
Tetracyacline  
 
       The oxidation of tetracycline by ferrate(VI) has been conducted and a stoichiometry of 1.4:1 
(Fe(VI):tetracycline) was proposed (eq 4) (Yang & Doong 2006).   
1.4 FeO42- + tetracycline  1.4 Fe(III) + O2 + product(s)     (4) 
The effect of pH on the degradation of tetracycline showed that the removal efficiency of 
tetracycline increased with increase in pH (Figure 1).  The efficiency was only 35% at pH 7.5, 
but increased to 53-64% when the pH of solutions were higher than 8.3.  The results clearly 
demonstrate that pH is a critical parameter in controlling the degradation of tetracycline by 
ferrate(VI).  
The degradation of tetracycline by ferrate(VI) was also examined by the electrospray 
ionization-mass spectrometry (ESI-MS) technique (Yang & Doong 2007).  In an experiment 200 
µM tetracycline was mixed with 50 µM ferrate(VI)  and the spectral analysis of tetracycline 
before and after the reaction was carried out.  An expected abundant peak at m/z 410.0 and a 
small peak at m/z 427 appeared for tetracycline before mixing with ferrate(VI) (Cherlet et al. 
2003).  After the reaction, a substantial decrease in peaks at m/z 445 and 410 was observed, 
clearly showing the degradation of tetracycline by ferrate(VI).  Additionally, total organic carbon 
(TOC) analysis also showed that the TOC decreased from an initial concentration of 17.65 mg-
C/L to 15.65 mg-C/L after the reaction.   However, it is difficult to identify the possible products 
from the ESI-MS spectra and TOC analysis from the results obtained in this study.  Further 
experiments are necessary to clarify the mechanisms and reactive pathways of tetracycline by 
ferrate(VI).  
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CONCLUSIONS 
Although ferrate(VI) has shown promise to be capable of oxidizing organic micro-
pollutants at low levels, the reactions of ferrate(VI) with a wide range of EDs and PCCPs have 
yet to be investigated to fully assess the potential of ferrate(VI) to degrade these compounds.  
The kinetic data on pharmaceuticals are only limited to sulfonamides and ibuprofen; hence, it is 
important to include other drug molecules.  Moreover, the nature of the products formed during 
the oxidation of EDs and pharmaceuticals by ferrate(VI) remains relatively unknown.  Because 
the products can be toxic during transformation of such compounds, it is imperative to perform 
product studies on the oxidation by ferrate(VI). Finally, it is important to note that the 
application of ferrate(VI) offers the additional treatment mechanism of coagulation/solid phase 
adsorption via its reduced Fe(III) species, and thus future studies need to evaluate the overall 
effect of oxidation and coagulation/adsorption on the removal of the parent compounds and 
daughter products. 
 
REFERENCES  
 
Carbala, M., Omil, F., Lema, J.M., Llompart, M., Garcia-Jares, C., Rodriguez, I., Gomez, M. & 
Ternes, T. 2004 Behavior of pharmaceuticals, cosmetics, and hormones in a sewage treatment 
plant.  Water Res. 38, 2918-2926. 
 
Cherlet, M., Schelkens, M., Croubels, S. & De Becker, P. 2003 Quantitative multi-residue 
analysis of tetracyclines and their 4-epimers in pig tissues by high-performance liquid 
chromatography combined with positive-ion electrospray ionization mass spectrometry. Anal. 
Chim. Acta  492, 199-213. 
 
Condies, L.W. 1986 Toxicological problems associated with chlorine dioxide.  J. Am. Water 
Works Assoc. June, 73-78. 
 
Deborde, M., Rabouan, S., Gallard, H. & Legube, B. 2004 Aqueous chlorination kinetics of 
some endocrine disruptors. Environ. Sci. Technol. 38, 5577-5583. 
 
Dodd, M.C. & Huang, C-H. 2004 Transformation of the antibacterial agent sulfamethoxazole in 
reactions with chlorine: kinetics, mechanisms, and pathways. Environ. Sci. Technol. 38, 5607-
 11
5615.  
 
Dodd, M.C. & Huang, C-H.  2007 Aqueous chlorination of the antibacterial agent trimethoprim: 
reaction kinetics and pathways.  Water Res. 41, 647-655. 
 
Gates, D. 1998 The Chlorine Dioxide Handbook.  American Water Works Association, Denver, 
Colorado. 
 
Gibson, R., Smith, M.D., Spary, C.J., Tyler, C.R. & Hill, E.M. 2005 Mixtures of estrogenic 
contaminants in bile of fish exposed to wastewater treatment works effluents.  Environ. Sci. 
Technol. 39, 2461-2471. 
 
Gould, I.M. 1999 A review of the role of antibiotic policies in the control of antibiotic resistance.  
J. Antimicrob. Chemother. 43, 459-465. 
 
Hu, J-Y., Aizawa, T. & Ookubo, S. 2002 Products of aqueous chlorination of bisphenol A and 
their estrogenic activity. Environ. Sci. Technol. 36, 1980-1987. 
 
Hu, J-Y., Cheng, S., Aizawa, T., Terao, Y. & Kunikane, S. 2003 Products of aqueous 
chlorination of 17β-estradiol and their estrogenic activity. Environ. Sci. Technol. 37, 5665-5670. 
 
Huber, M.M., Canonica, S., Park, G-Y. & Gunten, U.V. 2003 Oxidation of pharmaceuticals 
during ozonation and advanced oxidation processes.  Environ. Sci. Technol 37, 1016-1024. 
 
Huber, M.M., Goebel, A., Joss, A., Hermann, N., Loffler, D., McArdell, C.S., Ried, A., Siegrist, 
H., Ternes, T.A. & Gunten, U.V. 2005 Oxidation of pharmaceuticals during ozonation of 
municipal wastewater effluents: a pilot study.  Environ. Sci. Technol. 39, 4290-4299.  
 
Jiang, J-Q. & Lloyd, B. 2002 Progress in the development and use of ferrate(VI) salt as an 
oxidant and coagulant for water and wastewater treatment. Water Res. 36, 1397-1408. 
 
Jiang, J.Q., Yin, Q., Zhou, J.L. & Pearce, P. 2005 Occurrence and treatment trials of endocrine 
disrupting chemicals (EDCs) in wastewater. Chemosphere 61, 544-550. 
 
Jobling, S., Nolan, M., Tyler, C.R., Brighty, G. & Sumpter, J.P. 1998 Widespread sexual 
disruption in wild fish.  Environ. Sci. Technol. 32, 2498-2506. 
 
Khetan, S.K. & Collins, T.J. 2007 Human pharmaceuticals in the aquatic environment: a 
challenge to green chemistry. Chem. Rev. 107, 2319-2364. 
 
Lee, B-C., Kamata, M., Akatsuka, Y., Takeda, M., Ohno, K., Kamei, T. & Magara, Y. 2004 
Effects of chlorine on the decrease of estrogenic chemicals.  Water Res. 38, 733-739. 
 
Lee, Y., Yoon, J. & Gunten, U.V. 2005 Kinetics of the oxidation of phenols and phenolic 
endocrine disruptors during water treatment with ferrate (Fe(VI)).  Environ. Sci. Technol. 39, 
8978-8984. 
 12
 
Li, C., Li, X.Z. & Graham, N. 2005 A study of the preparation and reactivity of potassium ferrate. 
Chemosphere, 61, 537-543. 
 
Li, C., Li, X.Z., Graham, N. & Gao, N.Y. 2007 The aqueous degradation of bisphenol and 
steroid estrogens by ferrate.  Water Res., In press. 
 
Lutz, I. & Kloas, W. 1999 Amphibians as a model to study endocrine disruptors: I. 
Environmental pollution and estrogen receptor binding.  Sci. Total Environ. 225, 49-57. 
 
Miao, X., Bishay, F., Chen, M. & Metcalfe, C.D. 2004  Occurrence of antimicrobials in the final 
effluents of wastewater treatment plants in Canada.  Environ. Sci. Technol. 38, 3533-3541. 
 
Mills, L.J. & Chichester, C. 2005 Review of evidence: an endocrine-disrupting chemicals in the 
aquatic environment impacting fish populations? Science Total Environ. 343, 1-34. 
 
Ning, B., Graham, N., Zhnag, Y., Nakonechny, M., El-Din, M.G. 2007 The degradation of 
endocrine-disrupting chemicals by ozone and AOPs – a review. Ozone: Sci. Eng. 29, 1-24. 
 
Ongerth, J.E. & Khan, S. 2004 Drug Residuals: How xenobiotics can affect water supply sources. 
J.-Am. Water Works Assoc. 96, 94-101. 
 
Pinkson, K.E. & Sedlak, D.L 2004 Transformation of aromatic ether- and amine-containing 
pharmaceuticals during chlorine disinfection.  Environ. Sci. Technol. 38, 4019-4025. 
 
Pomati, F., Castiglioni, S., Zuccato, E., Fanelli, R., Vigetti, D., Rossetti, C. & Calamari, D. 2006 
Effect of a complex mixture of therapeutic drugs at environmental levels on human embryonic 
cells.  Environ. Sci. Technol. 40, 2442-2447. 
 
 
Sharma, V.K. 2002 Potassium ferrate(VI): an environmentally friendly oxidant. Adv. Environ. 
Res. 6, 143-156. 
 
Sharma, V.K., Kazama, F., Jiangyong, H. & Ray, A.K. 2005a Ferrates (iron(VI) and iron(V) as 
environmentally friendly oxidants and disinfectants. J. Water Health  3, 42-58. 
 
Sharma, V.K., Burnett, C.R., Yngard, R. & Cabelli, D.E. 2005b Iron(VI) and iron(V) oxidation 
of copper(I) cyanide. Environ. Sci. Technol. 39, 3849-3854. 
 
Sharma, V.K. & Mishra, S.K. 2006 Ferrate(VI) oxidation of ibuprofen: a kinetic study.  Environ. 
Chem. Lett. 3, 182-185. 
 
Sharma, V.K., Mishra, S.K. & Nesnas, N. 2006a Oxidation of sulfonamide antimicrobials by 
ferrate(VI) [FeVIO42-], Environ. Sci. Technol. 40, 7222-7227.  
 
 13
Sharma, V.K., Mishra, S.K. & Ray, A.K. 2006b Kinetic assessment of the potassium ferrate(VI) 
oxidation of antibacterial drug, sulfamethoxazole. Chemosphere 62, 128-134. 
 
Sharma, V.K. 2007a A review of disinfection performance of Fe(VI) in water and wastewater. 
Water Sci. Technol. 55, 225-230. 
 
Sharma, V.K. 2007b Ferrate Studies for Disinfection and Treatment of Drinking Water, In: 
Advances in Control of Disinfection By-Products in Drinking Water Systems (Eds. A. Nikolaou, 
L. Rizzo, and H. Selcuk), Nova Science Publishers, Chapter 7, pp 1-6. 
 
Snyder, S.A., Westerhoff, P., Yoon, Y. & Sedlak, D.L. 2003 Pharmaceuticals, personal care 
products, and endocrine disruptors in water: implications for water industry.  Environ. Engg. Sci. 
20, 449-469. 
 
Ternes, T.A., Meisenheimer, M., Mcdowell, D., Sacher, F., Brauch, H-J., Haist-Gulde B., Preuss 
G., Wilme, U. & Zulei-Seibert, N. 2002  Removal of pharmaceutical during drinking water 
treatment.  Environ. Sci. Technol. 36, 3855-3863. 
 
Ternes, T.A., Joss, A. & Siegrist, H. 2004 Scrutinizing pharmaceuticals and personal care 
products in wastewater treatment.  Environ. Sci. Technol. 20, 393A-399A. 
 
Westerhoff, P., Yoon, Y., Snyder, S. & Wert, E. 2006 Fate of endocrine-disruptor, 
pharmaceutical, and personal care product chemicals during simulated drinking water treatment 
processes.  Environ. Sci. Technol. 40, 6649-6663. 
 
Weyer, P. & Riley, D. 2001 Endocrine Disruptors and Pharmaceuticals in Drinking Water; 
AWWA Research Foundation: Denver, Colorado. 
 
Yang, S.F. & Doong, R-A. 2007 Preparation of potassium ferrate for the degradation of 
tetracyacline.  ACS symposium Series 985, In Press. 
 
 14
Table 1.  Second-order rate constants for selected EDs and antibiotics in reaction with 
ferrate(VI) (pH 7.0 and 8.0; 25 oC). 
____________________________________________________________________________ 
Compound   k (M-1s-1)  t1/2*  k (M-1s-1)  t1/2* 
     pH 8.0     pH 7.0  
____________________________________________________________________________ 
   
EDCs1 
 
Bisphenol A (BPA)  4.29x102  32.3 s  6.50x102  21.2 s 
  
17α-ethynylestradiol (EE2) 6.88x102  21.1 s  8.13x102  17.0 s 
 
Estrone (E1)    1.05x103  13.1 s  1.01x103  13.7 s 
 
Β-estradiol (E2)   1.09x103  12.6 s  1.09x103  12.6 s 
 
Estriol (E3)    1.29x103  11.6 s  1.18x103  10.9 s 
 
Antimicrobials2 
 
Sulfisoxazole   3.520.10x102  39.3 s  1.500.03x103  9.2 s 
 
Sulfamethazine  1.110.02x102  125 s  1.050.08x103  13.2 s 
 
Sulfamethizole  0.380.01x102  365 s  4.090.41x102  33.9 s 
 
Sulfadimethoxine  -   -  0.790.07x102  175 s 
 
Sulfamethoxazole  0.460.02x102  301 s  1.330.08x103  10.4 s  
______________________________________________________________________________ 
*assuming 10 mg/L K2FeO4 dose 
1 The rate constants calculated using the values and kinetic equation (12) given in Li et al (2007) 
2Sharma et al (2006) 
 
 
 
 
 
 
 15
Scheme I 
 16
Scheme II 
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Figure 1.  Degradation of tetracycline by ferrate(VI) at different pH.  Experimental conditions: 
[Ferrate(VI)] = 50 µM; [Tetracycline] = 200 µM ( adapted from Yang & Doong 2007). 
 
